Home » In Focus » Jennifer Fulton to Present on ADaM Issues at 2021 CDISC US Interchange

Jennifer Fulton to Present on ADaM Issues at 2021 CDISC US Interchange

Jennifer Fulton Senior Biostatistician.

October 13, 2021

Jennifer Fulton, M.S., a Westat biostatistician, will provide a case study on CDISC ADaM phases, periods, and subperiods at the 2021 CDISC US Interchange to be held October 18-22, 2021, a hybrid conference event.

Jennifer Fulton, M.S., a Westat biostatistician, will provide a case study on CDISC ADaM phases, periods, and subperiods at the 2021 CDISC US Interchange to be held October 18-22, 2021, a hybrid conference event. The theme of this year’s meeting is With Standards—Science Will Prevail.

Ms. Fulton will provide her virtual presentation on October 20, 2021, at 4:30 pm (ET). ADaM is one of the required standards for data submission to the Food and Drug Administration. Many typical clinical studies are comprised simply of screening, treatment, and follow-up time periods. Occasionally the treatment portion of the study needs to be divided further into analysis periods, and subperiods. “This paper will present a case study on an actual clinical trial that presented interesting challenges for the correct implementation of the ADaM guidelines for these variables,” notes Ms. Fulton.

More News

  • Westat Sponsors Texas Life Science Forum

    Westat Sponsors Texas Life Science Forum

  • Westat Presents at 2022 DIA Annual Meeting

    Westat Presents at 2022 DIA Annual Meeting

  • Safe Site Monitoring and Management During COVID-19

    Safe Site Monitoring and Management During COVID-19